Home > Healthcare > Medical Devices > Diagnostic Devices > Central Nervous System Biomarkers Market

Central Nervous System Biomarkers Market Share

Report ID: GMI8335
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Central Nervous System Biomarkers Market Share

The central nervous system biomarkers industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced devices based on different technologies is a key market strategy. Some of the leading industry players including F. Hoffmann-La Roche Ltd, Novartis AG, and Thermo Fisher Scientific, Inc, among others have a notable presence in the market.

Central Nervous System Biomarkers Market Companies

Some of the eminent market participants operating in the central nervous system biomarkers industry include:

bioMerieux
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
G-Biosciences
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Novartis AG
PerkinElmer Inc.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Central nervous system biomarkers market size was USD 5.6 billion in 2023 and is expected to register 8.1% CAGR from 2024-2032 owing to the increasing prevalence of neurological disorders worldwide.

The safety biomarker segment recorded USD 2.5 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their significance in clinical trials to monitor and assess the safety profile of new drugs.

North America central nervous system biomarkers industry reached USD 2.3 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of the world's leading research institutions focused on neuroscience and biomarker development in the region.

F. Hoffmann-La Roche Ltd, G-Biosciences, Illumina, Inc., Merck KGaA, Myriad Genetics, Inc., Novartis AG, PerkinElmer Inc., Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific Inc., are some of the major central nervous system biomarkers companies worldwide.